A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

NCT05293548 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
516
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

National Vaccine and Serum Institute, China

Collaborators